Giant cystic pheochromocytoma masquerading as acute coronary syndrome and transient left ventricular dysfunction: a case report


  • Sryma P. B. Department of Medicine, Government Medical College, Thrissur, Kerala, India
  • Mary Grace N. C. Department of Medicine, Government Medical College, Thrissur, Kerala, India
  • Abdul Siyad A. K. Department of Medicine, Government Medical College, Thrissur, Kerala, India
  • Ijas Ahamed Department of Medicine, Government Medical College, Thrissur, Kerala, India



Cardiomyopathy, Labile hypertension, Pheochromocytoma


Objective of present study to present an atypical manifestation of pheochromocytoma and to illustrate the difficulty in managing an acute coronary syndrome and left ventricular dysfunction during a hypertensive crisis attributable to pheochromocytoma. We present the clinical history, physical findings, lab results and imaging studies of a 62year old man with acute coronary syndrome later found to have an adrenal mass. A 62-year-old man was suspected of having myocardial ischemia on the basis of symptoms of paroxysmal chest discomfort, diaphoresis, ST-segment elevation on an electrocardiogram, and elevated levels of cardiac enzymes. Coronary CT angiography was normal. Echocardiography revealed substantial ballooning of the apical, anterior, and inferior cardiac walls, consistent with catecholamine induced cardiomyopathy. He had a history of labile hypertension, headache, diaphoresis and palpitations of 4 years' duration. A right adrenal mass detected on Magnetic resonance imaging and increased plasma catecholamine levels were consistent with a pheochromocytoma. Treatment with prazosin and labetalol was initiated, and he underwent a right adrenalectomy, which confirmed thepheochromocytoma. Pheochromocytomas must be considered in the setting of acute coronary syndrome especially with presence of labile blood pressure. Inadvertent fibrinolysis can be avoided with proper clinical suspicion and timely coronary imaging.


Adler JT, Meyer-Rochow GY, Chen H, Benn DE, Robinson BG, Sippel RS, et al. Pheochromocytoma: current approaches and future directions. Oncologist. 2008 Jul;13(7):779-93.

Tsirlin A, Oo Y, Sharma R, Kansara A, Gliwa A, Banerji MA. Pheochromocytoma: a review. Maturitas. 2014 Mar;77(3):229-38.

Andreoni C, Krebs RK, Bruna PC, Goldman SM, Kater CE, Alves MTS, et al. Cystic phaeochromocytoma is a distinctive subgroup with special clinical, imaging and histological features that might mislead the diagnosis. BJU Int. 2008 Feb;101(3):345-50.

Sica DA. Endocrine Causes of secondary hypertension. J Clin Hypertens. 2008 Jul 1;10(7):534-40.

Pourian M, Mostafazadeh DB, Soltani A. Does this patient have pheochromocytoma? A systematic review of clinical signs and symptoms. J Diabetes Metab Disord. 2016;15:11.

Fessel J, Robertson D. Orthostatic hypertension: when pressor reflexes overcompensate. Nat Clin Pract Nephrol. 2006;2(8):424-31.

Yu R, Nissen NN, Bannykh SI. Cardiac complications as initial manifestation of pheochromocytoma: frequency, outcome, and predictors. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2012 Aug;18(4):483-92.

Maharaj R, Parbhu S, Ramcharan W, Baijoo S, Greaves W, Harnanan D, et al. Giant cystic pheochromocytoma with low risk of malignancy: a case report and literature review. Case Rep Oncol Med. 2017;2017:4638608.






Case Reports